Ashish Kacholia spotlight: Board approves allotment of 3,70,000 shares in multibagger pharma micro-cap; company secures purchase commitment from first public sector drug manufacturer!
Ashish Kacholia spotlight: Board approves allotment of 3,70,000 shares in multibagger pharma micro-cap; company secures purchase commitment from first public sector drug manufacturer!

Ashish Kacholia spotlight: Board approves allotment of 3,70,000 shares in multibagger pharma micro-cap; company secures purchase commitment from first public sector drug manufacturer!

The stock has proven its mettle with a staggering 333.59 per cent multibagger return in the past year, firmly establishing itself as a micro-cap gem with a market cap of Rs 170 crore

Karan Dsij Article rating: 4.4

This pharmaceutical juggernaut has not only surged by an impressive 2 per cent, triggering an upper circuit, but it has also clinched a fresh 52-week high at Rs 169.80.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR